INMUNE BIO INC. Cash and Restricted Cash
INMUNE BIO INC. (INMB) had Cash and Restricted Cash of $18.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.41M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.36M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.75M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.73M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $18.41M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $21.36M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $24.75M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $27.73M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $33.37M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $19.34M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $20.92M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $33.55M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $31.07M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $26.00M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $35.85M 10-K · filed 2026-03-30 |
| 2023-09-30 | $41.81M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $47.83M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $51.00M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $52.15M 10-K · filed 2025-03-27 |
| 2022-09-30 | $57.41M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $61.21M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $66.73M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $74.81M 10-K · filed 2024-03-28 |
| 2020-12-31 | $21.97M 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |